Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics
Mesenchymal stem cells (MSC) are, due to their immunosuppressive and regenerative properties, used as new therapeutic agents in cell-based therapy of inflammatory and degenerative diseases. A large number of experimental and clinical studies revealed that most of MSC-mediated beneficial effects were...
Main Authors: | Carl Randall Harrell, Nemanja Jovicic, Valentin Djonov, Vladislav Volarevic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/5/474 |
Similar Items
-
Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders
by: Carl Randall Harrell, et al.
Published: (2021-02-01) -
Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases
by: Carl Randall Harrell, et al.
Published: (2022-04-01) -
NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases
by: Carl Randall Harrell, et al.
Published: (2023-09-01) -
Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Ocular Graft-Versus-Host Disease
by: Carl Randall Harrell, et al.
Published: (2022-10-01) -
The Cross-Talk between Mesenchymal Stem Cells and Immune Cells in Tissue Repair and Regeneration
by: Carl Randall Harrell, et al.
Published: (2021-03-01)